The Biomarkers Market is expected to be around US$ 131.60 Billion by 2028 at a CAGR of 14% in the given forecast period.
Factors such as the rising demand for customized medicine and companion diagnostics are vital growth drivers for the biomarkers market. Rising consumer awareness, a expanding patient base, development of technologies in clinical laboratory tests, and imaging exams, are other key drivers of the biomarkers market. The rising number of CROs and the reduced cost of clinical trials in several developing economies has added boost to the market growth. Moreover, the growing R&D activities funded by pharmaceutical and biotechnology companies with the increasing prevalence of cancer are significant trends fueling the demand for biomarkers and thus, propelling the market growth. The increasing usage of biomarkers in medical fields such as cancer treatment and research will boost the future growth of the biomarkers market.
The global Biomarkers market is segregated on the basis of Types as Biomarker of Exposure and Biomarker of Diseases. Based on Applications the global Biomarkers market is segmented in Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery and Development, Drug Formulation, Forensic Application and Others. Based on Services, the global Biomarkers market is segmented in Sample Preparation, Assay Development, Biomarker Validation and Testing and Other Services.
The global Biomarkers market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biomarkers market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Qiagen N.V., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd, PerkinElmer Inc., Merck KGaA, Bio-Rad Laboratories, Abbott Laboratories, EKF Diagnostics, Enzo Biochem Inc., Meso Scale Diagnostics, LLC, Signosis, PerkinElmer Inc., Johnson & Johnson Services, Inc., Biosims Technologies Sas, and others are among the major players in the global Biomarkers market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biomarkers Market has been segmented below:
Biomarkers Market, By Types
Biomarkers Market, By Applications
Biomarkers Market, By Services
Biomarkers Market, By Region
Biomarkers Market, By Company
The report covers:
Report Scope:
The global Biomarkers market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biomarkers market share. Major industry players with significant revenue share include Qiagen N.V., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd, PerkinElmer Inc., Merck KGaA, Bio-Rad Laboratories, Abbott Laboratories, EKF Diagnostics, Enzo Biochem Inc., Meso Scale Diagnostics, LLC, Signosis, PerkinElmer Inc., Johnson & Johnson Services, Inc., Biosims Technologies Sas, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Electrophoresis Reagents Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Biomarkers Market, By Types
5.1. Introduction
5.2. Biomarker of Exposure
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Biomarker of Diseases
5.3.1. Market Overview
5.3.2. Market Size and Forecast
6. Biomarkers Market, By Applications
6.1. Introduction
6.2. Risk Assessment
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Development of Molecular Diagnostic
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Disease Diagnosis
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Drug Discovery and Development
6.5.1. Market Overview
6.5.2. Market Size and Forecast
6.6. Drug Formulation
6.6.1. Market Overview
6.6.2. Market Size and Forecast
6.7. Forensic Application
6.7.1. Market Overview
6.7.2. Market Size and Forecast
6.8. Others
6.8.1. Market Overview
6.8.2. Market Size and Forecast
7. Biomarkers Market, By Services
7.1. Introduction
7.2. Sample Preparation
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Assay Development
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Biomarker Validation and Testing
7.4.1. Market Overview
7.4.2. Market Size and Forecast
7.5. Other Services
7.5.1. Market Overview
7.5.2. Market Size and Forecast
8. Biomarkers Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. North America Biomarkers, By Types
8.2.2. North America Biomarkers, By Applications
8.2.3. North America Biomarkers, By Services
8.3. Europe
8.3.1. Europe Biomarkers, By Types
8.3.2. Europe Biomarkers, By Applications
8.3.3. Europe Biomarkers, By Services
8.4. Asia-Pacific
8.4.1. Asia-Pacific Biomarkers, By Types
8.4.2. Asia-Pacific Biomarkers, By Applications
8.4.3. Asia-Pacific Biomarkers, By Services
8.5. Rest of the World
8.5.1. Rest of the World Biomarkers, By Types
8.5.2. Rest of the World Biomarkers, By Applications
8.5.3. Rest of the World Biomarkers, By Services
9. Competitive Insights
9.1. Key Insights
9.2. Company Market Share Analysis
9.3. Strategic Outlook
9.3.1. Mergers & Acquisitions
9.3.2. New Product Developments
9.3.3. Portfolio/Production Capacity Expansions
9.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5. Others
10. Company Profiles
10.1. Qiagen N.V.,
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Thermo Fisher Scientific Inc.,
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Hoffmann-La Roche Ltd,
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. PerkinElmer Inc.,
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Merck KGaA,
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Bio-Rad Laboratories,
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Abbott Laboratories,
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. EKF Diagnostics,
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Enzo Biochem Inc.,
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Meso Scale Diagnostics, LLC,
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Signosis
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. PerkinElmer Inc.
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
10.13. Johnson & Johnson Services, Inc.
10.13.1. Company Overview
10.13.2. Product/Service Landscape
10.13.3. Financial Overview
10.13.4. Recent Developments
10.14. Biosims Technologies Sas
10.14.1. Company Overview
10.14.2. Product/Service Landscape
10.14.3. Financial Overview
10.14.4. Recent Developments
The Biomarkers Market has been segmented below:
Biomarkers Market, By Types
Biomarkers Market, By Applications
Biomarkers Market, By Services
Biomarkers Market, By Region
Biomarkers Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
